GL1X · GenesisL1 explorer

Research workbench

The crystal structures of holo-and apo-cellular retinol binding protein II

Analyse The crystal structures of holo-and apo-cellular retinol binding protein II in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1OPB
Type
protein
Length
532 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cellular retinol binding protein II
UniProt
P06768
Ligands
RET
Pockets
8 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 11% helix, 56% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DCellular retinol binding protein IIprotein13311% helix, 56% strandP06768

Ligands and binding sites

  • RET · Retinal · ligand · 4 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12960.830.9435RET
22850.830.9436RET
32770.820.9335RET
42780.820.9336RET
5930.570.8621empty

Interfaces

4 interfaces between chains.

  • A–D · 444 Ų buried · 12 hydrogen bonds · protein-protein
  • A–B · 395 Ų buried · 8 hydrogen bonds · protein-protein
  • C–D · 394 Ų buried · 8 hydrogen bonds · protein-protein
  • B–C · 28 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 1OPB · The crystal structures of holo-and apo-cellular retinol binding protein II · the same entry in another collection · chain B against B, TM-score 1.00
  • P06768 · AlphaFold monomer V2.0 prediction for retinol-binding protein 2 (P06768) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.